Pharmaceutical
| Fri 31 Jan 2025
Alexandria, Feb. 1 -- Beijing Shenogen Pharma Group has been awarded a patent for SHP2 phosphatase allosteric inhibitor. This invention was developed by Wang Huting, Zhang Lei, Wang Yonggang, Fan Lixin, Liu Lei, Wei Dong, Wang Jing, Wang Jiaojiao, Mo Dongliang, Jin Mingji, Peng Yong and Meng Kun.
The patent application number..